Next Article in Journal
Absolute Bioavailability and Metabolism of Dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (“tetraene”) after Intravenous and Oral Single Doses to Rats
Previous Article in Journal
Falcarinol Content in Carrot Genotypes Determined by LC-MS
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 77
Issue 6
10.3797/scipharm.oephg.21.SL-27
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Reverse Chemical Proteomics in Drug Discovery

by
M. GOTSBACHER
* and
P. KARUSO
Department of Chemistry & Biomolecular Sciences, Macquarie University, Sydney, NSW, 2109 Australia
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(6), 194; https://doi.org/10.3797/scipharm.oephg.21.SL-27
Submission received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009
Versions Notes

Abstract

With advances in separation technology and structure elucidation, the main bottleneck limiting drug development from natural products is the identification of their cellular targets. Although effective therapeutic agents can be developed and successfully administered without knowledge of the underlying mechanism of action, elucidation of drug target proteins is essential in the design of new compounds with improved safety and efficacy [1].[...]

Share and Cite

MDPI and ACS Style

GOTSBACHER, M.; KARUSO, P. Reverse Chemical Proteomics in Drug Discovery. Sci. Pharm. 2009, 77, 194. https://doi.org/10.3797/scipharm.oephg.21.SL-27

AMA Style

GOTSBACHER M, KARUSO P. Reverse Chemical Proteomics in Drug Discovery. Scientia Pharmaceutica. 2009; 77(Short Lectures (SL)):194. https://doi.org/10.3797/scipharm.oephg.21.SL-27

Chicago/Turabian Style

GOTSBACHER, M., and P. KARUSO. 2009. "Reverse Chemical Proteomics in Drug Discovery" Scientia Pharmaceutica 77, Short Lectures (SL): 194. https://doi.org/10.3797/scipharm.oephg.21.SL-27

APA Style

GOTSBACHER, M., & KARUSO, P. (2009). Reverse Chemical Proteomics in Drug Discovery. Scientia Pharmaceutica, 77(Short Lectures (SL)), 194. https://doi.org/10.3797/scipharm.oephg.21.SL-27

Article Metrics

Back to TopTop